35 results
424B3
PRTG
Portage Biotech Inc
7 Nov 23
Prospectus supplement
4:50pm
patent protection for our products;
the recruitment or departure of key personnel;
market conditions in the pharmaceutical and biotechnology sectors
F-1
PRTG
Portage Biotech Inc
31 Oct 23
Registration statement (foreign)
4:05pm
or other proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our products;
the recruitment
424B5
PRTG
Portage Biotech Inc
2 Oct 23
Prospectus supplement for primary offering
6:01pm
, including patents, litigation matters and our ability to obtain patent protection for our products;
the recruitment or departure of key personnel
424B5
i9oc9iao3z8bk9rlduq
19 Aug 22
Prospectus supplement for primary offering
10:52am
SUPPL
av7pod65tqfrycox
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
h8l5kbn3 3g
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B5
k33bkdqv2 qikr35
8 Mar 21
Prospectus supplement for primary offering
5:03pm
F-3
q8epvblzn7 k35dx7p98
24 Feb 21
Shelf registration (foreign)
5:22pm
6-K
EX-99.1
993cjuyl86q21e4
28 May 20
Report of Foreign Private Issuer
12:19pm
6-K
5jcor5
16 Apr 20
Report of Foreign Private Issuer
11:27am
6-K
EX-99.2
vm485o549 rmi
31 Dec 19
Consolidated Interim Financial Statements
10:03am
6-K
g11a40 c2
11 Jul 19
Report of Foreign Issuer
1:36pm
6-K
EX-99.1
fkbm2pzk58
19 Feb 19
Report of Foreign Private Issuer
10:37am